The global nonmydriatic handheld fundus camera market size is expected to reach USD 186.4 million by 2025, according to a new report by Grand View Research, Inc., registering a 9.1% CAGR during the forecast period. Increasing geriatric population has resulted in higher prevalence of age-related macular degeneration (AMD). Furthermore, rising incidence of diabetic retinopathy is expected to increase demand for ophthalmic screening devices, subsequently driving demand for nonmydriatic handheld fundus cameras.
According
to laws and regulations by various medical devices agencies in U.S. as well as
Japan, fundus imaging cameras must be replaced once in every four years. Hence,
demand for these devices is likely to increase in these developed countries in
the coming years. Supportive government regulations such as these are likely to
have a positive impact on the nonmydriatic handheld fundus camera market.
Approximately
80.0% cases of blindness due to chronic diseases can be avoided by continuous
and effective screening. Screening is the only way of detecting eye diseases at
an early stage. In U.S., fundus photography procedures are covered by Medicare
under CPT code 92250. Growing insurance coverage for such procedures is also
likely to boost demand for handheld fundus cameras.
Full Research Report On Nonmydriatic Handheld Fundus Camera Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/nonmydriatic-handheld-fundus-camera-market
Nonmydriatic
Handheld Fundus Camera Market Report Highlights
- Demand for portable fundus cameras is expected to
grow at a rapid rate due to its ergonomic design and user convenience.
This is expected to contribute to the growth of the nonmydriatic handheld
fundus camera market
- According to the National Eye Institute, the
number of people suffering from diabetic retinopathy, aged 40 and above,
in U.S. is estimated to reach 11.4 million by 2030
- North America held a majority market share in
2017 due to increasing prevalence of vision related disorders, growing
awareness about their treatments, and technological advancements in
digital medical devices
- Government initiatives being undertaken for
quality, affordable, and speedy healthcare delivery are likely to drive
the market. Medicare, for instance, covers the cost of cataract surgery,
ocular prosthesis, and glaucoma screening
- Increasing number of product approvals in U.S.
has led to adoption of improved technologies by ophthalmologists. For
instance, Topcon Medical Systems received clearance for 3D OCT-1 Maestro
from the U.S. FDA in July 2016
- Asia Pacific is anticipated to be one of the
fastest growing regional markets over the forecast period due to presence
of a large patient pool, improved healthcare services, and increasing
medical tourism in the region
- Some of the key companies active in the market
are Topcon Medical Systems, Inc.; Carl Zeiss Meditec Group; Optomed Oy
(Ltd.); OptoVue, Inc.; NIDEK Co., Ltd.; Canon, Inc.; and Clarity Medical
Systems, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/nonmydriatic-handheld-fundus-camera-market/request/rs1
Nonmydriatic
Handheld Fundus Camera Market Segmentation
Grand View Research has
segmented the global nonmydriatic handheld fundus camera market based on
region:
Nonmydriatic
Handheld Fundus Camera Region Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment